CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
|
0.730 |
CausalMutation
|
disease |
CLINVAR |
Structure of the polyisoprenyl-phosphate glycosyltransferase GtrB and insights into the mechanism of catalysis.
|
26729507 |
2016 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
The present case is the first individual described with DPM1-CDG (CDG-Ie) to also have clinical and muscle biopsy findings consistent with dystroglycanopathy.
|
23856421 |
2013 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The present case is the first individual described with DPM1-CDG (CDG-Ie) to also have clinical and muscle biopsy findings consistent with dystroglycanopathy.
|
23856421 |
2013 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
The present case is the first individual described with DPM1-CDG (CDG-Ie) to also have clinical and muscle biopsy findings consistent with dystroglycanopathy.
|
23856421 |
2013 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The present case is the first individual described with DPM1-CDG (CDG-Ie) to also have clinical and muscle biopsy findings consistent with dystroglycanopathy.
|
23856421 |
2013 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
|
0.730 |
CausalMutation
|
disease |
CLINVAR |
The present case is the first individual described with DPM1-CDG (CDG-Ie) to also have clinical and muscle biopsy findings consistent with dystroglycanopathy.
|
23856421 |
2013 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
|
0.730 |
GeneticVariation
|
disease |
BEFREE |
A new intronic mutation in the DPM1 gene is associated with a milder form of CDG Ie in two French siblings.
|
16641202 |
2006 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
|
0.730 |
Biomarker
|
disease |
BEFREE |
CDG Ie is caused by a deficiency of dolichol-phosphate-mannose synthase 1 (DPM1), an enzyme involved in N-glycan assembly in the endoplasmic reticulum.
|
15669674 |
2004 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
CDG Ie is caused by a deficiency of dolichol-phosphate-mannose synthase 1 (DPM1), an enzyme involved in N-glycan assembly in the endoplasmic reticulum.
|
15669674 |
2004 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
CDG Ie is caused by a deficiency of dolichol-phosphate-mannose synthase 1 (DPM1), an enzyme involved in N-glycan assembly in the endoplasmic reticulum.
|
15669674 |
2004 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie)
|
10642597 |
2000 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
|
0.730 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Because DPM1 deficiency, like other subtypes of CDG-I, impairs the assembly of N-glycans, this novel glycosylation defect was named CDG-Ie.
|
10642602 |
2000 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
|
0.730 |
GeneticVariation
|
disease |
UNIPROT |
Because DPM1 deficiency, like other subtypes of CDG-I, impairs the assembly of N-glycans, this novel glycosylation defect was named CDG-Ie.
|
10642602 |
2000 |
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
|
0.730 |
Biomarker
|
disease |
CTD_human |
|
|
|
Congenital Disorders of Glycosylation
|
0.330 |
Biomarker
|
group |
BEFREE |
The structures also rationalize the loss of dolichylphosphate mannose synthase function in dpm1-associated CDG.The generation of glycolipid dolichylphosphate mannose (Dol-P-Man) is a critical step for protein glycosylation and GPI anchor synthesis.
|
28743912 |
2017 |
Congenital Disorders of Glycosylation
|
0.330 |
GeneticVariation
|
group |
BEFREE |
The present case is the first individual described with DPM1-CDG (CDG-Ie) to also have clinical and muscle biopsy findings consistent with dystroglycanopathy.
|
23856421 |
2013 |
Congenital Disorders of Glycosylation
|
0.330 |
GeneticVariation
|
group |
BEFREE |
Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie)
|
10642597 |
2000 |
Congenital Disorders of Glycosylation
|
0.330 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
Congenital disorder of glycosylation type 1q
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie)
|
10642597 |
2000 |
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Patent ductus arteriosus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Failure to Thrive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hemangioma
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hepatomegaly
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|